Otorhinolaryngologic Neoplasms D010039

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Head and Neck Neoplasms » Otorhinolaryngologic Neoplasms

Diseases [C] » Otorhinolaryngologic Diseases [C09] » Otorhinolaryngologic Neoplasms

Description

A general concept for tumors or cancer of any part of the EAR; the NOSE; the THROAT; and the PHARYNX. It is used when there is no specific heading.   MeSH

Hierarchy View

Subtype Terms (5)

Ear Neoplasms
 

Laryngeal Neoplasms
41 drugs (28 approved, 13 experimental)

Neuroma, Acoustic
19 drugs (13 approved, 6 experimental)

Nose Neoplasms
5 approved drugs

Pharyngeal Neoplasms
14 drugs (13 approved, 1 experimental)


Other Experimental Indicated Drugs (2)


Organization Involved with Phase 2 Indications (1)

Organization Involved with Other Experimental Indications (4)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.